MOH — authorised 25 May 2007
- Marketing authorisation holder: UCB INC
- Status: likely_approved
MOH authorised Xyzal on 25 May 2007
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 25 May 2007.
UCB INC holds the Israeli marketing authorisation.